BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 10310397)

  • 1. Capital formation and DRGs.
    Raske KE; Wilson PA
    Mich Hosp; 1983 Oct; 19(10):15-7. PubMed ID: 10310397
    [No Abstract]   [Full Text] [Related]  

  • 2. Capital budgeting under DRGs. Meeting a new challenge.
    Kee RC; Grant EW
    OH; 1984; 28(7):10-3, 22-3. PubMed ID: 10310668
    [No Abstract]   [Full Text] [Related]  

  • 3. Perspectives. Capital under DRGs.
    Wash Rep Med Health; 1985 Jan; 39(3):suppl 4p. PubMed ID: 10310966
    [No Abstract]   [Full Text] [Related]  

  • 4. A securities analyst views capital cost reimbursement.
    Gargiulo GT
    Health Manage Q; 1984; ():6-9. PubMed ID: 10273589
    [No Abstract]   [Full Text] [Related]  

  • 5. The discount rate for capital expenditure analysis in health care.
    Wheeler JR; Smith DG
    Health Care Manage Rev; 1988; 13(2):43-51. PubMed ID: 3273480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congress wants to legislate Medicare capital payment cuts.
    Baldwin MF
    Mod Healthc; 1986 Mar; 16(7):124, 126, 128. PubMed ID: 10300618
    [No Abstract]   [Full Text] [Related]  

  • 7. Financial tools in evaluating profit and DRG cost determination.
    Wilson CN
    Hosp Pharm; 1984 Oct; 19(10):703-5. PubMed ID: 10273580
    [No Abstract]   [Full Text] [Related]  

  • 8. Financial manager's notebook. How to evaluate the return on your investment.
    Pearce JW
    Healthc Financ Manage; 1984 Jul; 38(7):113-4. PubMed ID: 10315571
    [No Abstract]   [Full Text] [Related]  

  • 9. Will payments for capital costs be tied to DRGs?
    Simler SL
    Mod Healthc; 1983 Apr; 13(4):26. PubMed ID: 10309920
    [No Abstract]   [Full Text] [Related]  

  • 10. What's the controversy behind capital payment under prospective pricing?
    Warner G
    Trustee; 1984 Sep; 37(9):39-40. PubMed ID: 10273576
    [No Abstract]   [Full Text] [Related]  

  • 11. Capital reimbursement and health planning: more than a matter of cost-containment.
    Abernethy D
    Health Manage Q; 1984; ():2-5. PubMed ID: 10299739
    [No Abstract]   [Full Text] [Related]  

  • 12. For timely decision making a capital equipment acquisition process.
    Oszustowicz RJ
    Hosp Financ Manage; 1982 Apr; 36(4):12-5, 18-9, 24-33. PubMed ID: 10254866
    [No Abstract]   [Full Text] [Related]  

  • 13. Equipment acquisition under prospective pricing.
    Goodhart M
    Hosp Cap Finance; 1985; 2(4):7-8. PubMed ID: 10274580
    [No Abstract]   [Full Text] [Related]  

  • 14. Capital payment under PPS: can hospitals still bloom?
    Nash D; Haught JA; Hopkins A; Oxler K; Rovinsky M
    Healthc Financ Manage; 1986 Apr; 40(4):29-37. PubMed ID: 10300594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Data, analysis and policy options. Medicare payment of hospital capital-related costs.
    Rubin RJ; Helms RB
    Healthc Financ Manage; 1984 Apr; 38(4):21-8. PubMed ID: 10315525
    [No Abstract]   [Full Text] [Related]  

  • 16. Financing for improvements and capital expenditures.
    McLaughlin DB; Peterson K
    Top Health Rec Manage; 1985 Dec; 6(2):22-6. PubMed ID: 10311361
    [No Abstract]   [Full Text] [Related]  

  • 17. Tracking capital costs by product line is key.
    Riffer J
    Hospitals; 1986 Jun; 60(12):68. PubMed ID: 3710453
    [No Abstract]   [Full Text] [Related]  

  • 18. Assessing financial capabilities: debt capacity analysis is critical to planning.
    Fitz TE
    Healthc Financ Manage; 1983 Jan; 37(1):52-8. PubMed ID: 10315262
    [No Abstract]   [Full Text] [Related]  

  • 19. The ABCs of DRGs.
    Goldberg L
    Group Pract J; 1983; 32(5):9, 12-6. PubMed ID: 10310438
    [No Abstract]   [Full Text] [Related]  

  • 20. Capital costs rise; fixed costs bear burden of more debt.
    Solovy A
    Hospitals; 1989 May; 63(10):24. PubMed ID: 2654001
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.